Two Distinct Gonorrhea Trends and Risk Factors Among Women in Australia.


Journal

Sexually transmitted diseases
ISSN: 1537-4521
Titre abrégé: Sex Transm Dis
Pays: United States
ID NLM: 7705941

Informations de publication

Date de publication:
01 2020
Historique:
entrez: 20 12 2019
pubmed: 20 12 2019
medline: 21 11 2020
Statut: ppublish

Résumé

In recent years, gonorrhea notifications have increased in women in Australia and other countries. We measured trends over time and risk factors among Australian Aboriginal and Torres Strait Islander ("Aboriginal") and non-Aboriginal women. We conducted a cross-sectional analysis of data from 41 sexual health clinics. Gonorrhea positivity at each patient's first visit (first-test positivity) during the period 2009 to 2016 was calculated. Univariate and multivariate analyses assessed risk factors for first-test positivity in Aboriginal and non-Aboriginal women. Gonorrhea positivity decreased among Aboriginal women (7.1% in 2009 to 5.2% in 2016, P < 0.001) and increased among non-Aboriginal women (0.6%-2.9%, P < 0.001). Among Aboriginal women, first-test positivity was independently associated with living in a regional or remote area (adjusted odds ratio [aOR], 4.29; 95% confidence interval [CI], 2.52-7.31; P < 0.01) and chlamydia infection (aOR, 4.20; 95% CI,3.22-5.47; P < 0.01). Among non-Aboriginal women, first-test positivity was independently associated with greater socioeconomic disadvantage (second quartile: aOR, 1.68 [95% CI, 1.31-2.16; P < 0.01]; third quartile: aOR, 1.54 [95% CI, 1.25-1.89; P < 0.01]) compared with least disadvantaged quartile: recent sex work (aOR, 1.69; 95% CI, 1.37-2.08; P < 0.01), recent injecting drug use (aOR, 1.85; 95% CI, 1.34-2.57; P < 0.01), and chlamydia infection (aOR, 2.35; 95% CI, 1.90-2.91; P < 0.01). For non-Aboriginal women, being aged 16 to 19 years (aOR, 0.62; 95% CI, 0.49-0.80; P < 0.01) compared with those ≥30 years was a protective factor. These findings highlight 2 different epidemics and risk factors for Aboriginal and non-Aboriginal women, which can inform appropriate health promotion and clinical strategies.

Sections du résumé

BACKGROUND
In recent years, gonorrhea notifications have increased in women in Australia and other countries. We measured trends over time and risk factors among Australian Aboriginal and Torres Strait Islander ("Aboriginal") and non-Aboriginal women.
METHODS
We conducted a cross-sectional analysis of data from 41 sexual health clinics. Gonorrhea positivity at each patient's first visit (first-test positivity) during the period 2009 to 2016 was calculated. Univariate and multivariate analyses assessed risk factors for first-test positivity in Aboriginal and non-Aboriginal women.
RESULTS
Gonorrhea positivity decreased among Aboriginal women (7.1% in 2009 to 5.2% in 2016, P < 0.001) and increased among non-Aboriginal women (0.6%-2.9%, P < 0.001). Among Aboriginal women, first-test positivity was independently associated with living in a regional or remote area (adjusted odds ratio [aOR], 4.29; 95% confidence interval [CI], 2.52-7.31; P < 0.01) and chlamydia infection (aOR, 4.20; 95% CI,3.22-5.47; P < 0.01). Among non-Aboriginal women, first-test positivity was independently associated with greater socioeconomic disadvantage (second quartile: aOR, 1.68 [95% CI, 1.31-2.16; P < 0.01]; third quartile: aOR, 1.54 [95% CI, 1.25-1.89; P < 0.01]) compared with least disadvantaged quartile: recent sex work (aOR, 1.69; 95% CI, 1.37-2.08; P < 0.01), recent injecting drug use (aOR, 1.85; 95% CI, 1.34-2.57; P < 0.01), and chlamydia infection (aOR, 2.35; 95% CI, 1.90-2.91; P < 0.01). For non-Aboriginal women, being aged 16 to 19 years (aOR, 0.62; 95% CI, 0.49-0.80; P < 0.01) compared with those ≥30 years was a protective factor.
CONCLUSIONS
These findings highlight 2 different epidemics and risk factors for Aboriginal and non-Aboriginal women, which can inform appropriate health promotion and clinical strategies.

Identifiants

pubmed: 31856073
doi: 10.1097/OLQ.0000000000001086
pii: 00007435-202001000-00009
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

34-40

Références

Kirby Institute. HIV, Viral Hepatitis and Sexually Transmissible Infections in Australia: Annual Surveillance Report 2018. Sydney: Kirby Institute, UNSW Sydney, 2018.
Misson J, Chow EPF, Chen MY, et al. Trends in gonorrhoea infection and overseas sexual contacts among females attending a sexual health centre in Melbourne, Australia, 2008–2015. Commun Dis Intell (2018) 2018; 42.
Graham S, Guy RJ, Donovan B, et al. Epidemiology of chlamydia and gonorrhoea among Indigenous and non-Indigenous Australians, 2000–2009. Med J Aust 2012; 197:642–646.
Detels R, Green AM, Klausner JD, et al. The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five Countries. Sex Transm Dis 2011; 38:503–509.
Kirby Institute. Bloodborne Viral and Sexually Transmissible Infections in Aboriginal and Torres Strait Islander People: Annual Surveillance Report 2018. Sydney: Kirby Institute, UNSW Sydney, 2018.
Graham S, Smith LW, Fairley CK, et al. Prevalence of chlamydia, gonorrhoea, syphilis and trichomonas in Aboriginal and Torres Strait Islander Australians: A systematic review and meta-analysis. Sex Health 2016; 13:99–113.
Garton L, Dyda A, Guy R, et al. High chlamydia and gonorrhoea repeat positivity in remote Aboriginal communities 2009–2011: Longitudinal analysis of testing for re-infection at 3 months suggests the need for more frequent screening. Sex Health 2016; 13:568–574.
Silver B, Kaldor JM, Rumbold A, et al. Community and clinic-based screening for curable sexually transmissible infections in a high prevalence setting in Australia: A retrospective longitudinal analysis of clinical service data from 2006 to 2009. Sex Health 2016; 13:140–147.
Bowden FJ, Paterson BA, Mein J, et al. Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and human papillomavirus infection in indigenous women in northern Australia. Sex Transm Infect 1999; 75:431–434.
Choudhri Y, Miller J, Sandhu J, et al. Gonorrhea in Canada, 2010–2015. Can Commun Dis Rep 2018; 44:37–42.
Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2017. Atlanta, GA: Department of Health and Human Services, 2018.
Public Health England. Sexually Transmitted Infections and Screening for Chlamydia in England, 2017. UK, 2018. Contract No.: 20.
Aral SO, Adimora AA, Fenton KA. Understanding and responding to disparities in HIV and other sexually transmitted infections in African Americans. Lancet 2008; 372:337–340.
Reekie J, Donovan B, Guy R, et al. Risk of ectopic pregnancy and tubal infertility following gonorrhea and chlamydia infections. Clin Infect Dis 2019; 69:1621–1623.
Heumann CL, Quilter LA, Eastment MC, et al. Adverse birth outcomes and maternal Neisseria gonorrhoeae infection: A population-based cohort study in Washington State. Sex Transm Dis 2017; 44:266–271.
Tuttle CS, Van Dantzig T, Brady S, et al. The epidemiology of gonococcal arthritis in an Indigenous Australian population. Sex Transm Infect 2015; 91:497–501.
World Health Organization. Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria gonorrhoeae. Geneva: World Health Organization, 2012.
Australian Bureau of Statistics. 2076.0—Census of Population and Housing: Characteristics of Aboriginal and Torres Strait Islander Australians, 2016 2016 Updated 13 March 2019. Available at: https://www.abs.gov.au/ausstats/abs@.nsf/mf/2076.0. Accessed June 21, 2019.
Cornelisse VJ, Chow EP, Huffam S, et al. Increased detection of pharyngeal and rectal gonorrhea in men who have sex with men after transition from culture to nucleic acid amplification testing. Sex Transm Dis 2017; 44:114–117.
Royal Australian College of General Practitioners. Guidelines for Preventive Activities in General Practice. Melbourne: RACGP, 2012.
Donovan B, Dimech W, Ali H, et al. Increased testing for Neisseria gonorrhoeae with duplex nucleic acid amplification tests in Australia: Implications for surveillance. Sex Health 2015; 12:48–50.
SA Health. Notifiable STIs and partner notification South Australia. 2019 Available at: https://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/health+services/sexual+health+services/adelaide+sexual+health+centre/sexually+transmitted+infections+for+health+professionals/notifiable+stis+and+partner+notification. Accessed August 29, 2019.
Wozniak TM, Moore HA, MacIntyre CR. Epidemiology of sexually transmissible infections in New South Wales: Are case notifications enough? Commun Dis Intell Q Rep 2013; 37:E407–E414.
ACON. Sexual Health Sydney, Australia 2019 Available at: https://www.acon.org.au/what-we-are-here-for/sexual-health/. Accessed August 29, 2018.
Australian Sexual Health Alliance. Australian STI Management Guidelines Australia 2018; updated March 2018. Available at: http://www.sti.guidelines.org.au/. Accessed April 28, 2019.
Callander D, Moriera C, El-Hayek C, et al. Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS): A protocol for monitoring the control of sexually transmissible infections and blood borne viruses (Preprint). JMIR Res Protoc 2018; 35:1–4.
Ward J, Bryant J, Wand H, et al. Sexual Health and Relationships in Young Aboriginal and Torres Strait Islander People: Results From the First National Study Assessing Knowledge, Risk Practices and Health Service Use in Relation to Sexually Transmitted Infections and Blood Borne Viruses. Alice Springs: Australia Baker IDI Heart & Diabetes Institute, 2014. Available at: https://www.baker.edu.au/Assets/Files/Final%20Goanna%20Report%20July%202014.pdf. Accessed October 29, 2019.
Callander D, Moreira C, El-Hayek C, et al. Monitoring the control of sexually transmissible infections and blood-borne viruses: Protocol for the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS). JMIR Res Protoc 2018; 7:e11028.
Australian Bureau of Statistics. Australian Statistical Geography Standard (ASGS). 2011.
Australian Bureau of Statistics. Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), Australia, 2016 Canberra Australian Bureau of Statistics 2018; Available at: http://www.abs.gov.au/ausstats/abs@.nsf/mf/2033.0.55.001. Accessed October 25, 2018.

Auteurs

Kate Whitford (K)

From the The Kirby Institute, UNSW Sydney, Sydney, Australia.

Lucy Watchirs Smith (LW)

From the The Kirby Institute, UNSW Sydney, Sydney, Australia.

Rebecca Guy (R)

From the The Kirby Institute, UNSW Sydney, Sydney, Australia.

Marlene Kong (M)

From the The Kirby Institute, UNSW Sydney, Sydney, Australia.

James Ward (J)

South Australian Health and Medical Research Institute, Adelaide.

Basil Donovan (B)

From the The Kirby Institute, UNSW Sydney, Sydney, Australia.

Hamish McManus (H)

From the The Kirby Institute, UNSW Sydney, Sydney, Australia.

Skye McGregor (S)

From the The Kirby Institute, UNSW Sydney, Sydney, Australia.

Arun Menon (A)

Townsville Sexual Health Service, Queensland.

Catherine C O'Connor (CC)

From the The Kirby Institute, UNSW Sydney, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH